FindTrial
Sign In

The adding of low-dose droperidol can alleviate postoperative nausea and vomiting in patients after bariatric surgery

The adding of low-dose droperidol can alleviate postoperative nausea and vomiting in patients after bariatric surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300070012
Enrollment
Unknown
Registered
2023-03-31
Start date
2022-12-12
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative nausea and vomiting after bariatric surgery

Interventions

Addition of droperidol group:no
patients who did not accept droperidol:no

Sponsors

Beijing Friendship Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 63 Years

Inclusion criteria

Inclusion criteria: (1) patines who underwent bariatric surgery and accepted the Acute Pain Research postoperative follow-up (2) postoperative follow-up was conducted in the postoprative day and 6 hours after patients back in the ward (3) patients=18 years old (4) patients volunteered to finish the postoperative follow-up

Exclusion criteria

Exclusion criteria: 1. patients who accepted reoperation 2. patients who refused to accept the postoperative follow-up

Design outcomes

Primary

MeasureTime frame
postoperative nausea and vomiting;—

Secondary

MeasureTime frame
acute pain scores;—

Countries

China

Contacts

Public ContactYujing Yuan

Beijing Friendship Hospital, Capital Medical University

yuanyujing1228@126.com13718490336

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026